SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Action Pharma's Phase 2b Clinical Trial with AP214 to Prevent Kidney Injury Associated with Major Cardiac Surgery Demonstrates Positive Top-Line Results